An Indispensable Parameters of Cephalexin Include Indications, Mechanism of Action, Administration, Adverse Effects and Toxicity
Abstract
Cephalexin is a first-generation cephalosporin antibiotic that was licensed by the US Food and Drug Administration (FDA) in 1970. Due to its superior safety and efficacy profile, this medication is widely utilized in both inpatient and outpatient healthcare settings. Cephalexin is frequently used to treat otitis media, respiratory infections, urinary tract infections, bone infections caused by Proteus mirabilis or Staphylococcus aureus, and skin and soft tissue infections caused by Streptococcus pyogenes or S. aureus. To reduce the incidence of surgical site infections and other bacterial infections, cephalexin is given prophylactically. These infections can be caused by both staphylococcal and streptococcal species. This thorough exercise provides a review of cephalexin's indications, mechanism of action, contraindications, and side effects, allowing the interprofessional healthcare team to use it appropriately in patient care.
References
Bailey, A., Walker, A., Hadley, A., & James, D. G. (1970). Cephalexin—a new oral antibiotic. Postgraduate Medical Journal, 46(533), 157–158.
Derrick, C. W., & Reilly, K. (1983). The role of cephalexin in the treatment of skin and soft-tissue infections. Postgraduate Medical Journal, 59(Suppl. 5), 43–46.
Valent, A. M., DeArmond, C., Houston, J. M., Reddy, S., Masters, H. R., Gold, A., Boldt, M., DeFranco, E., Evans, A. T., & Warshak, C. R. (2017). Effect of post-cesarean delivery oral cephalexin and metronidazole on surgical site infection among obese women: A randomized clinical trial. JAMA, 318(11), 1026–1034.
Committee on Practice Bulletins—Obstetrics. (2018). ACOG Practice Bulletin No. 199: Use of prophylactic antibiotics in labor and delivery. Obstetrics & Gynecology, 132(3), e103–e119.
Lieberthal, A. S., Carroll, A. E., Chonmaitree, T., Ganiats, T. G., Hoberman, A., Jackson, M. A., Joffe, M. D., Miller, D. T., Rosenfeld, R. M., Sevilla, X. D., Schwartz, R. H., Thomas, P. A., & Tunkel, D. E. (2013). The diagnosis and management of acute otitis media. Pediatrics, 131(3), e964–e999.
Pandey, N., & Cascella, M. (2023). Beta-lactam antibiotics. In StatPearls. StatPearls Publishing.
Thompson, J. W., & Jacobs, R. F. (1993). Adverse effects of newer cephalosporins: An update. Drug Safety, 9(2), 132–142.
Gwee, A., Autmizguine, J., Curtis, N., & Duffull, S. B. (2020). Twice- and thrice-daily cephalexin dosing for Staphylococcus aureus infections in children. The Pediatric Infectious Disease Journal, 39(6), 519–522.
National Institute of Child Health and Human Development. (2024, November 15). Cephalexin. In Drugs and Lactation Database (LactMed®). National Library of Medicine.
Pichichero, M. E. (2006). Cephalosporins can be prescribed safely for penicillin-allergic patients. The Journal of Family Practice, 55(2), 106–112.
Wilcox, M. H., Chalmers, J. D., Nord, C. E., Freeman, J., & Bouza, E. (2017). Role of cephalosporins in the era of Clostridium difficile infection. Journal of Antimicrobial Chemotherapy, 72(1), 1–18.
Thiessen, K., & Kraleti, S. (2017). Cephalexin-induced haemolytic anaemia: A case report. Journal of Clinical Pharmacy and Therapeutics, 42(5), 615–617.
Baradhi, K. M., Ahmed, S., & Buford, M. L. (2015). The case | Acute renal failure after antibiotic treatment for bronchitis. Diagnosis: Pigment nephropathy from cephalexin-induced immune hemolytic anemia. Kidney International, 87(6), 1269–1270.
Manoharan, A., & Kot, T. (1987). Cephalexin-induced haemolytic anaemia. Medical Journal of Australia, 147(4), 202.
DaCunha, M., Moore, S., & Kaplan, D. (2018). Cephalexin-induced acute generalized exanthematous pustulosis. Dermatology Reports, 10(2), Article 7686.
Everts, R. J., Gardiner, S. J., Zhang, M., Begg, R., Chambers, S. T., Turnidge, J., & Begg, E. J. (2021). Probenecid effects on cephalexin pharmacokinetics and pharmacodynamics in healthy volunteers. Journal of Infection, 83(2), 182–189.
Bathini, L., Jandoc, R., Kuwornu, P., McArthur, E., Weir, M. A., Sood, M. M., Battistella, M., Muanda, F. T., Liu, A., Jain, A. K., & Garg, A. X. (2019). Clinical outcomes of failing to dose-reduce cephalosporin antibiotics in older adults with CKD. Clinical Journal of the American Society of Nephrology, 14(2), 197–205.
Refbacks
- There are currently no refbacks.